Loading...
research article
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
June 11, 2020
Assessing the burden of COVID-19 on the basis of medically attended case numbers is suboptimal given its reliance on testing strategy, changing case definitions, and disease presentation. Population-based serosurveys measuring anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) antibodies provide one method for estimating infection rates and monitoring the progression of the epidemic. Here, we estimate weekly seroprevalence of anti-SARS-CoV-2 antibodies in the population of Geneva, Switzerland, during the epidemic.
Type
research article
Authors
Stringhini, Silvia
•
Wisniak, Ania
•
Piumatti, Giovanni
•
Azman, Andrew S
•
Lauer, Stephen A
•
Baysson, Hélène
•
De Ridder, David
•
Petrovic, Dusan
•
Schrempft, Stephanie
•
Marcus, Kailing
Publication date
2020-06-11
Published in
Volume
396
Issue
10247
Start page
313
End page
319
Peer reviewed
REVIEWED
EPFL units
Available on Infoscience
June 19, 2020
Use this identifier to reference this record